Rapid control of ectopic cushing’s syndrome during the covid-19 pandemic in a patient with chronic hypokalaemia

1Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

In this case report, we describe the management of a patient who was admitted with an ectopic ACTH syndrome during the COVID pandemic with new-onset type 2 diabetes, neutrophilia and unexplained hypokalaemia. These three findings when combined should alert physicians to the potential presence of Cushing’s syndrome (CS). On admission, a quick diagnosis of CS was made based on clinical and biochemical features and the patient was treated urgently using high dose oral metyrapone thus allowing delays in surgery and rapidly improving the patient’s clinical condition. This resulted in the treatment of hyperglycaemia, hypokalaemia and hypertension reducing cardiovascular risk and likely risk for infection. Observing COVID-19 pandemic international guidelines to treat patients with CS has shown to be effective and offers endocrinologists an option to manage these patients adequately in difficult times.

Cite

CITATION STYLE

APA

Faisal, Z., & Debono, M. (2021). Rapid control of ectopic cushing’s syndrome during the covid-19 pandemic in a patient with chronic hypokalaemia. Endocrinology, Diabetes and Metabolism Case Reports, 2021(1). https://doi.org/10.1530/EDM-21-0038

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free